Rapport Therapeutics Inc....

NASDAQ: RAPP · Real-Time Price · USD
14.66
-0.28 (-1.87%)
At close: Aug 15, 2025, 3:59 PM
14.57
-0.61%
After-hours: Aug 15, 2025, 05:51 PM EDT

Rapport Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
56.8M 70.17M 31.16M
Short-Term Investments
248.47M 77.31M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
160K 551K n/a
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
4.52M 3.31M 109K
Total Current Assets
309.8M 150.87M 31.27M
Property-Plant & Equipment
4.97M 4M 335K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
5.13M 4.55M 335K
Total Assets
314.93M 155.42M 31.6M
Account Payables
1.95M 2.5M 1.45M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
737K 670K n/a
Other Current Liabilities
2.97M 2.55M n/a
Total Current Liabilities
8.77M 8.8M 1.66M
Long-Term Debt
n/a 4.2M 10.44M
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
739K 5.68M 10.44M
Total Liabilities
9.51M 14.48M 12.1M
Total Debt
1.48M 2.15M 10.44M
Common Stock
37K 4K 31K
Retained Earnings
-123.75M -45.44M -10.65M
Comprehensive Income
-522K 4K -31K
Shareholders Equity
305.43M 140.94M 19.5M
Total Investments
248.47M 77.31M n/a